Lets dive in and see how it works for you
72 h, 6.2) levels following 5FU treatment (Fig
During the period for patient inclusion in our study (20172021), 8596.5% of all patients receiving drugs for diabetes in Sweden (as registered in the National Prescription Drug Register) were included in the register [20,21,22,23,24]
Mayatepek E, Okun JG, Meissner T, Assmann B, Hammond J, Zschocke J, Lehmann WD: Synthesis and metabolism of leukotrienes in gamma-glutamyl transpeptidase deficiency
The compound's ability to facilitate both fatty acid oxidation and glucose metabolism positions it as a metabolic regulator capable of addressing multiple aspects of metabolic syndrome simultaneously